Becton Dickinson Receivables 2010-2024 | BDX
Becton Dickinson receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
- Becton Dickinson receivables for the quarter ending September 30, 2024 were $2.596B, a 7.54% increase year-over-year.
- Becton Dickinson receivables for 2023 were $2.534B, a 15.65% increase from 2022.
- Becton Dickinson receivables for 2022 were $2.191B, a 6.77% decline from 2021.
- Becton Dickinson receivables for 2021 were $2.35B, a 2% decline from 2020.
Becton Dickinson Annual Receivables
(Millions of US $) |
| 2023 |
$2,534 |
| 2022 |
$2,191 |
| 2021 |
$2,350 |
| 2020 |
$2,398 |
| 2019 |
$2,345 |
| 2018 |
$2,319 |
| 2017 |
$1,744 |
| 2016 |
$1,618 |
| 2015 |
$1,618 |
| 2014 |
$1,187 |
| 2013 |
$1,240 |
| 2012 |
$1,250 |
| 2011 |
$1,229 |
| 2010 |
$1,205 |
| 2009 |
$1,169 |
Becton Dickinson Quarterly Receivables
(Millions of US $) |
| 2024-06-30 |
$2,596 |
| 2024-03-31 |
$2,559 |
| 2023-12-31 |
$2,267 |
| 2023-09-30 |
$2,534 |
| 2023-06-30 |
$2,414 |
| 2023-03-31 |
$2,413 |
| 2022-12-31 |
$2,282 |
| 2022-09-30 |
$2,191 |
| 2022-06-30 |
$2,218 |
| 2022-03-31 |
$2,303 |
| 2021-12-31 |
$2,177 |
| 2021-09-30 |
$2,350 |
| 2021-06-30 |
$2,078 |
| 2021-03-31 |
$2,118 |
| 2020-12-31 |
$2,370 |
| 2020-09-30 |
$2,398 |
| 2020-06-30 |
$1,993 |
| 2020-03-31 |
$2,160 |
| 2019-12-31 |
$2,074 |
| 2019-09-30 |
$2,345 |
| 2019-06-30 |
$2,220 |
| 2019-03-31 |
$2,279 |
| 2018-12-31 |
$2,216 |
| 2018-09-30 |
$2,319 |
| 2018-06-30 |
$2,243 |
| 2018-03-31 |
$2,293 |
| 2017-12-31 |
$2,000 |
| 2017-09-30 |
$1,744 |
| 2017-06-30 |
$1,749 |
| 2017-03-31 |
$1,569 |
| 2016-12-31 |
$1,518 |
| 2016-09-30 |
$1,618 |
| 2016-06-30 |
$1,618 |
| 2016-03-31 |
$1,574 |
| 2015-12-31 |
$1,513 |
| 2015-09-30 |
$1,618 |
| 2015-06-30 |
$1,645 |
| 2015-03-31 |
$1,572 |
| 2014-12-31 |
$1,031 |
| 2014-09-30 |
$1,187 |
| 2014-06-30 |
$1,204 |
| 2014-03-31 |
$1,130 |
| 2013-12-31 |
$1,113 |
| 2013-09-30 |
$1,240 |
| 2013-06-30 |
$1,255 |
| 2013-03-31 |
$1,220 |
| 2012-12-31 |
$1,168 |
| 2012-09-30 |
$1,250 |
| 2012-06-30 |
$1,160 |
| 2012-03-31 |
$1,238 |
| 2011-12-31 |
$1,139 |
| 2011-09-30 |
$1,229 |
| 2011-06-30 |
$1,250 |
| 2011-03-31 |
$1,210 |
| 2010-12-31 |
$1,093 |
| 2010-09-30 |
$1,205 |
| 2010-06-30 |
$1,090 |
| 2010-03-31 |
$1,142 |
| 2009-12-31 |
$1,075 |
| 2009-09-30 |
$1,169 |
| 2009-06-30 |
$1,145 |
| 2009-03-31 |
$1,062 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$64.352B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
